Notably, treatments of tumor cells with HDAC inhibitors induce multiple effects, including cell cycle arrest, apoptosis, differentiation and senescence, modulation of immune response, altered angiogenesis, and restoration of sensitivity to drugs. Here, HDAC9 is linked to neoplasm.